{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:19:57Z","timestamp":1783102797423,"version":"3.54.6"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82560505"],"award-info":[{"award-number":["82560505"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013064","name":"Key Research and Development Program of Jiangxi Province","doi-asserted-by":"publisher","award":["20243BBI91024"],"award-info":[{"award-number":["20243BBI91024"]}],"id":[{"id":"10.13039\/501100013064","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijbiomac.2026.152479","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T06:48:03Z","timestamp":1778309283000},"page":"152479","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Ribonucleotide reductase regulatory subunit M2 as a macromolecular target bridging small cell lung cancer progression and SARS-CoV-2 infection"],"prefix":"10.1016","volume":"365","author":[{"given":"Hongquan","family":"Xing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weichang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqun","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2026.152479_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.605972","article-title":"Severe acute respiratory syndrome coronavirus 2-induced neurological complications","volume":"8","author":"Yu","year":"2020","journal-title":"Front. Cell Develop. Biol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.152479_bb0010","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.10880","article-title":"Differences in and cancer compared with those without cancer: a systematic review and meta-analysis","volume":"5","author":"Khoury","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.152479_bb0015","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.21037\/tlcr-20-269","article-title":"New molecular classification of large cell neuroendocrine carcinoma and small cell lung carcinoma with potential therapeutic impacts","volume":"9","author":"Lantuejoul","year":"2020","journal-title":"Transl. Lung Cancer Res."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.152479_bb0020","doi-asserted-by":"crossref","first-page":"5431","DOI":"10.1007\/s12325-021-01909-1","article-title":"Advances in treatment of recurrent Small Cell Lung Cancer (SCLC): insights for optimizing patient outcomes from an expert roundtable discussion","volume":"38","author":"Das","year":"2021","journal-title":"Adv. Ther."},{"issue":"15","key":"10.1016\/j.ijbiomac.2026.152479_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14153598","article-title":"Interactions between COVID-19 and lung cancer: lessons learned during the pandemic","volume":"14","author":"Bian","year":"2022","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.152479_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000849","article-title":"In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age","volume":"18","author":"Lieberman","year":"2020","journal-title":"PLoS Biol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.152479_bb0035","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41568-019-0133-9","article-title":"Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data","volume":"19","author":"Rudin","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ijbiomac.2026.152479_bb0040","article-title":"Network pharmacology and comparative transcriptome reveals biotargets and mechanisms of curcumol treating lung adenocarcinoma patients with COVID-19","volume":"9","author":"Yang","year":"2022","journal-title":"Front. Nutr."},{"key":"10.1016\/j.ijbiomac.2026.152479_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2022.147047","article-title":"Transcriptional profiles and common genes link lung cancer with the development and severity of COVID-19","volume":"852","author":"Cury","year":"2023","journal-title":"Gene"},{"key":"10.1016\/j.ijbiomac.2026.152479_bb0050","doi-asserted-by":"crossref","first-page":"1354663","DOI":"10.3389\/fpubh.2024.1354663","article-title":"Trends in genitourinary cancer mortality in the United States: analysis of the CDC-WONDER database 1999\u20132020","volume":"12","author":"Ghazwani","year":"2024","journal-title":"Front. Public Health"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.152479_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005895","article-title":"Genomic landscape survey identifies SRSF1 as a key oncodriver in small cell lung cancer","volume":"12","author":"Jiang","year":"2016","journal-title":"PLoS Genet."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152479_bb0060","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-021-01842-7","article-title":"Cell-autonomous immune gene expression is repressed in pulmonary neuroendocrine cells and small cell lung cancer","volume":"4","author":"Cai","year":"2021","journal-title":"Commun. Biol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.152479_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102711","article-title":"CD177, a specific marker of neutrophil activation, is associated with Coronavirus Disease 2019 severity and death","volume":"24","author":"L\u00e9vy","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.ijbiomac.2026.152479_bb0070","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.omtn.2022.07.005","article-title":"Significance of interferon signaling based on mRNA-microRNA integration and plasma protein analyses in critically ill COVID-19 patients","volume":"29","author":"Togami","year":"2022","journal-title":"Mol. Ther. Nucl. Acids"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.152479_bb0075","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41435-023-00210-1","article-title":"Systems-level profiling of early peripheral host-response landscape variations across COVID-19 severity states in an Indian cohort","volume":"24","author":"Banerjee","year":"2023","journal-title":"Genes Immun."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152479_bb0080","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1186\/s12885-025-14363-x","article-title":"Tracheal, bronchus, and lung cancer among older adults: thirty-year global burden trends, precision medicine breakthroughs, and lingering barriers","volume":"25","author":"Xing","year":"2025","journal-title":"BMC Cancer"},{"issue":"39","key":"10.1016\/j.ijbiomac.2026.152479_bb0085","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1021\/acs.jpcb.4c04901","article-title":"Introductory tutorials for simulating protein dynamics with GROMACS","volume":"128","author":"Lemkul","year":"2024","journal-title":"J. Phys. Chem. B"},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.152479_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27072370","article-title":"Molecular dynamics and MM-PBSA analysis of the SARS-CoV-2 Gamma Variant in complex with the hACE-2 receptor","volume":"27","author":"Cavani","year":"2022","journal-title":"Molecules (Basel, Switzerland)"},{"key":"10.1016\/j.ijbiomac.2026.152479_bb0095","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2025.2010","article-title":"Risk factors for COVID-19-related hospitalization and death in patients with cancer: The National Cancer Institute COVID-19 in Cancer Patients Study (NCCAPS)","author":"Rini","year":"2025","journal-title":"JAMA Oncol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152479_bb0100","first-page":"1562","article-title":"Real-world evidence of the impact of the COVID-19 pandemic on lung cancer","volume":"31","author":"Agulnik","year":"2024","journal-title":"Survival"},{"key":"10.1016\/j.ijbiomac.2026.152479_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.apjon.2025.100735","article-title":"COVID-19 related symptoms and the second infection status of SARS-CoV-2 in patients with lung cancer: a single-center, six-month longitudinal observational study","volume":"12","author":"Pan","year":"2025","journal-title":"Asia Pac. J. Oncol. Nurs."},{"key":"10.1016\/j.ijbiomac.2026.152479_bb0110","article-title":"COVID-19 among lung cancer patients: data from a real-life prospective French multicentric study","volume":"86","author":"Molinier","year":"2024","journal-title":"Respir. Med. Res."},{"issue":"20","key":"10.1016\/j.ijbiomac.2026.152479_bb0115","article-title":"Ribonucleotide reductase regulatory subunit M2 drives glioblastoma TMZ resistance through modulation of dNTP production","volume":"9","author":"Perrault","year":"2023"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152479_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.31501","article-title":"RRM2 is a putative biomarker and promotes bladder cancer progression via PI3K\/AKT\/mTOR pathway","volume":"240","author":"Guo","year":"2025","journal-title":"J. Cell. Physiol."},{"issue":"15","key":"10.1016\/j.ijbiomac.2026.152479_bb0125","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.1074\/jbc.RA118.004397","article-title":"Ribonucleotide reductase M2 promotes RNA replication of hepatitis C virus by protecting NS5B protein from hPLIC1-dependent proteasomal degradation","volume":"294","author":"Kitab","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.152479_bb0130","article-title":"Critical role for ribonucleoside-diphosphate reductase subunit M2 in ALV-J-induced activation of Wnt\/\u03b2-catenin signaling via interaction with P27","volume":"97","author":"Tang","year":"2023"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152479_bb0135","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13045-023-01432-6","article-title":"Cancer and COVID-19: unravelling the immunological interplay with a review of promising therapies against severe SARS-CoV-2 for cancer patients","volume":"16","author":"Leyfman","year":"2023","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152479_bb0140","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s41065-022-00258-5","article-title":"Identification of GINS1 as a therapeutic target in the cancer patients infected with COVID-19: a bioinformatics and system biology approach","volume":"159","author":"Hu","year":"2022","journal-title":"Hereditas"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152479_bb0145","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.gendis.2022.11.022","article-title":"Ribonucleotide reductase M2 (RRM2): Regulation, function and targeting strategy in human cancer","volume":"11","author":"Zuo","year":"2022","journal-title":"Genes Dis."},{"issue":"20","key":"10.1016\/j.ijbiomac.2026.152479_bb0150","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ade7236","article-title":"Ribonucleotide reductase regulatory subunit M2 drives glioblastoma TMZ resistance through modulation of dNTP production","volume":"9","author":"Perrault","year":"2023","journal-title":"Sci. Adv."},{"issue":"15","key":"10.1016\/j.ijbiomac.2026.152479_bb0155","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.1074\/jbc.RA118.004397","article-title":"Ribonucleotide reductase M2 promotes RNA replication of hepatitis C virus by protecting NS5B protein from hPLIC1-dependent proteasomal degradation","volume":"294","author":"Kitab","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152479_bb0160","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/07391102.2021.2002719","article-title":"Docking and molecular dynamics simulation for therapeutic repurposing in small cell lung cancer (SCLC) patients infected with COVID-19","volume":"41","author":"Pingali","year":"2023","journal-title":"J. Biomol. Struct. Dyn."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026024062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026024062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:48:53Z","timestamp":1783100933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026024062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":32,"alternative-id":["S0141813026024062"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.152479","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ribonucleotide reductase regulatory subunit M2 as a macromolecular target bridging small cell lung cancer progression and SARS-CoV-2 infection","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.152479","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152479"}}